GENERICS (U.K.) LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company acts as a service provider to the wider group, performing a range of Regional and Global functions which are then charged on to other group companies at a mark-up, therefore the company has the support of the group to continue in operational existence for the foreseeable future. The company has obtained a letter of support from its ultimate parent company to provide financial support for the foreseeable future, being at least 12 months from the date of the approval of these financial statements, which would enable the company to continue in operational existence for the foreseeable future by meeting its liabilities as they fall due.”

Significant events

• “On July 3, 2024, Viatris Inc. and Cooper Consumer Health SAS entered into a Transition Service Agreement (TSA) in conjunction with the signing of the Transaction Agreement. The services under the TSA commenced on the effective date and were concluded on July 3, 2025.”
• “On 28 March 2023, bodies of the national health authorities in England & Wales served a claim in the U.K. Competition Appeals Tribunal (CAT) against parties to the European Commission's decision, including the Company, seeking monetary damages, plus interest, purportedly arising from the settlement agreements. Currently the Company has sought permission to appeal this case to the Supreme Court against a preliminary decision of CAT, which is ongoing as of the date of issuance of these financial statements. The Company, beginning in approximately 2018, has received notices from other health service authorities and insurers asserting an intention to file similar claims.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -2.4%

  £73,493,000 → £71,699,000

• Cash

  +79.8%

  £57,332,000 → £103,067,000

• Net assets

  +11.3%

  £59,970,000 → £66,755,000

• Employees

  +8.1%

  246 → 266

• Operating profit

  +11%

  £1,783,000 → £1,979,000

• Profit before tax

  +18.3%

  £4,994,000 → £5,908,000

• Wages

  +11.4%

  £24,884,000 → £27,732,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers